ASBP
Price
$0.44
Change
+$0.04 (+10.00%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
N/A
KLRS
Price
$7.10
Change
+$0.50 (+7.58%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
123.44M
23 days until earnings call
Ad is loading...

ASBP vs KLRS

Header iconASBP vs KLRS Comparison
Open Charts ASBP vs KLRSBanner chart's image
Aspire Biopharma Holdings
Price$0.44
Change+$0.04 (+10.00%)
Volume$2.62K
CapitalizationN/A
Kalaris Therapeutics
Price$7.10
Change+$0.50 (+7.58%)
Volume$100
Capitalization123.44M
ASBP vs KLRS Comparison Chart
Loading...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. KLRS commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a StrongBuy and KLRS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (ASBP: $0.40 vs. KLRS: $6.60)
Brand notoriety: ASBP and KLRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 30% vs. KLRS: 224%
Market capitalization -- ASBP: $0 vs. KLRS: $123.44M
ASBP [@Biotechnology] is valued at $0. KLRS’s [@Biotechnology] market capitalization is $123.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileKLRS’s FA Score has 1 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • KLRS’s FA Score: 1 green, 4 red.
According to our system of comparison, KLRS is a better buy in the long-term than ASBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLRS’s TA Score shows that 3 TA indicator(s) are bullish.

  • KLRS’s TA Score: 3 bullish, 6 bearish.

Price Growth

ASBP (@Biotechnology) experienced а -31.14% price change this week, while KLRS (@Biotechnology) price change was -17.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.88%. For the same industry, the average monthly price growth was -20.27%, and the average quarterly price growth was -19.68%.

Reported Earning Dates

KLRS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-9.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KLRS YTD gains are higher at: 1471.429 vs. ASBP (-96.511).
ASBPKLRSASBP / KLRS
CapitalizationN/A123M-
EBITDAN/AN/A-
Gain YTD-96.5111471.429-7%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
KLRS
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
81%
View a ticker or compare two or three
Ad is loading...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSPJX16.870.04
+0.24%
Jackson Square Large-Cap Growth Inv
MUTHX23.17N/A
N/A
Franklin Mutual Shares Z
DTSVX21.14N/A
N/A
Wilshire Small Company Value Invmt
ROGSX38.27N/A
N/A
Red Oak Technology Select
PHSYX60.46-0.61
-1.00%
Putnam Global Health Care Y

ASBP and

Correlation & Price change

A.I.dvisor tells us that ASBP and BLUE have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASBP and BLUE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
-11.07%
BLUE - ASBP
26%
Poorly correlated
-3.64%
TVTX - ASBP
26%
Poorly correlated
+1.20%
BHVN - ASBP
24%
Poorly correlated
-3.66%
OCEA - ASBP
24%
Poorly correlated
-6.49%
EDIT - ASBP
22%
Poorly correlated
-2.91%
More

KLRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLRS has been loosely correlated with CHRO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if KLRS jumps, then CHRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLRS
1D Price
Change %
KLRS100%
-6.78%
CHRO - KLRS
41%
Loosely correlated
-3.94%
SPRO - KLRS
21%
Poorly correlated
+3.06%
ASBP - KLRS
3%
Poorly correlated
-11.07%
RNTX - KLRS
3%
Poorly correlated
-3.53%
OSRH - KLRS
2%
Poorly correlated
-21.54%
More